ABBV-744 IN COMBINATION WITH IMMUNOTHERAPY - AN OVERVIEW

The existing work examined the potential of utilizing ARV-825 and ABBV-744 to boost the effectiveness of tamoxifen or fulvestrant moreover palbociclib. ARV-825 was effective in the two p53 wild-style (WT) breast tumor cells and in cells missing functional p53 either on your own or in combination with tamoxifen, when the effectiveness of ABBV-744 wa